• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Trxade Health Inc (NQ: MEDS )

    7.590 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Trxade Health Inc

    < Previous 1 2 3 4 Next >
    TinyGemsBreaks – TRxAde Health Inc. (NASDAQ: MEDS) Changes Name to Scienture Holdings Inc.
    Via Investor Brand Network
    BioMedNewsBreaks — TRxADE Health Inc.’s (NASDAQ: MEDS) Subsidiary Expands Capabilities with Changes to Executive Leadership Team
    Via Investor Brand Network
    BioMedNewsBreaks — TRxAde Health Inc. (NASDAQ: MEDS), Scienture Inc. Announce All-Stock Business Combination Resulting in Combined Company
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Special Cash Dividend
    Via Investor Brand Network
    TRxADE HEALTH Reports First Quarter Gross Margin of 69% and Q1 2023 Financial Results
    Via ACCESSWIRE
    TRxADE HEALTH Reports 16% Revenue Growth and Year End 2022 Financial Results
    Via ACCESSWIRE
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Regains Compliance with Nasdaq Listing Rule 5250(c)(1), Posts Over $21M in Net Income for Q1 2024
    Via Investor Brand Network
    Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK
    Via AB Newswire
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Board Declares Special Cash Dividend
    Via Investor Brand Network
    TRxADE HEALTH Inc. (NASDAQ: MEDS) Leading the Way in Tuesday Trading Based on Percentage Gain
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Filing of Key Quarterly Report to Regain NASDAQ Exchange Compliance
    Via Investor Brand Network
    TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, Is Gearing Up To Make Big Splashes In the $151 Billion Snacks Industry with its Acquisition of The Urgent Company Inc.
    Via ACCESSWIRE
    TRxADE Health Inc. (NASDAQ: MEDS) Leading the Way in Friday Trading Based on Percentage Gain
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc.’s (NASDAQ: MEDS) Merger Partner Unveils Innovative Product It’s Bringing to Multibillion US Snacking Market
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Inks Acquisition Agreement with Perfect Day for Its Urgent Company, Consumer Brands Portfolio
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Files Extension for Form 10-Q Filing
    Via Investor Brand Network
    TRxADE HEALTH, INC. to Report Q2 2023 Financial Results on Monday, August 14th at 6:00 p.m. Eastern Time
    Via ACCESSWIRE
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Amended, Restates Superlatus Merger Agreement
    Via Investor Brand Network
    InvestorNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Inks MIPA in $10M NASDAQ Merger
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS), Superlatus Inc. to Merge and Create a Global Food Consolidation Platform
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Commences Trading After Board-Approved Reverse Stock Split
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q1 Financial Results
    Via Investor Brand Network
    TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 15th at 6:00 p.m. Eastern Time
    Via ACCESSWIRE
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Scheduled Release of Q1 2023 Financial Results, Conference Call
    Via Investor Brand Network
    TRxADE HEALTH, INC. to Report Q1 2023 Financial Results on Monday, May 8th at 5:00 p.m. Eastern Time
    Via ACCESSWIRE
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q4, Year-End 2022 Financial and Corporate Report
    Via Investor Brand Network
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Date for Release of Q4, Year-End 2022 Financial Report
    Via Investor Brand Network
    TRxADE HEALTH, INC. to Report Q4 and Year-End 2022 Financial Results on Monday, March 27th at 5:30 p.m. Eastern Time
    Via ACCESSWIRE
    InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Subsidiary Signs New Telemedicine Services Agreement
    Via Investor Brand Network
    Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model
    Via ACCESSWIRE
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.